SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 28, 2002
VITAL SIGNS, INC.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
New Jersey 0-18793 11-2279807
------------------------------------------------------------------------------
(State or other jurisdiction of (Commission (IRS Employer
incorporation or organization) File Number) Identification No.)
20 Campus Road, Totowa, New Jersey 07512
-------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (973) 790-1330
Item 5. Other Events.
On March 28, 2002, Vital Signs, Inc. (the "Company") consummated the
merger of Stelex, Inc. ("Stelex") into the Company's wholly-owned subsidiary,
The Validation Group, Inc. ("TVG"), with TVG continuing as the surviving entity.
The purchase price for the acquisition of Stelex was $13,300,000.
Item 7. Financial Statements and Exhibits.
Exhibit No. 99.1 Press Release, dated April 8, 2002.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
VITAL SIGNS, INC.
By: /s/ Joseph Bourgart
---------------------------------------
Joseph Bourgart
Executive Vice President
Dated: April 8, 2002
-2-
EXHIBIT INDEX
Exhibit No. 99.1 Press Release, dated April 8, 2002
-3-
STATEMENT OF DIFFERENCES
The section symbol shall be expressed as..............................'SS'